DUBLIN, December 18, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/8l43z2/immunotherapy) has announced the addition of the "Immunotherapy Drugs Market by Type of Drug, Epidemiology, Regulatory and Pipeline Analysis - Global Forecast to 2020" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The immunotherapy drugs market is expected to grow at a CAGR of 12.8% to reach USD 73,529.2 Million by 2020
In this report, the immunotherapy market is segmented into types of drugs and region. By types of drug, the market is further subsegmented into antibodies, interferons, interleukins, vaccines and checkpoint inhibitors.
The growing focus on cancer therapies with fewer side effects is a key factor driving the growth of the global immunotherapy drugs market. Other factors driving the market include high prevalence rate of lifestyle diseases including cancer, fast track and orphan drug designations expediting the review of drugs.
One of the most recent discoveries, the checkpoint inhibitors are expected to grow at highest rate during the forecast period among all the segments of cancer immunotherapy drugs. The growth of the segment is owing to the technological advancements and high efficacy.
The major drivers for the growth of immunotherapy drugs market are increasing incidence of different types of cancer; focus on targeted therapies with fewer side effects and quicker drug approval processes. On the other hand, the high cost of novel cancer therapies and limited knowledge of cancer immunobiology are the major factors hindering the growth of immunotherapy drugs market.
Key players in the immunotherapy drugs market include Amgen Inc. (U.S.), GlaxoSmithKline Plc. (U.K.), Merck & Co., Inc. (U.S.), Novartis International Ag (Switzerland),and Roche Holding Ag (Switzerland).
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Cancer Immunotherapy Market- Industry Insights
7 Immunotherapy Drugs Market, By Type of Drugs
8 Global Immunotherapy Drugs Market, By Region
9 Competitive Landscape
10 Company Profiles
- Amgen Inc.
- Bristol-Myers Squibb
- Celgene Corporation
- ELI Lilly and Company
- F. Hoffmann-La Roche Ag
- Glaxosmithkline Plc
- Merck & Co., Inc.
- Novartis International Ag
- Seattle Genetics, Inc.
- Spectrum Pharmaceuticals, Inc.
For more information visit http://www.researchandmarkets.com/research/8l43z2/immunotherapy
Research and Markets:
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
SOURCE Research and Markets